Open access
Open access
Powered by Google Translator Translator

Cohort Study | Development of interstitial lung disease among patients with atrial fibrillation receiving oral anticoagulants.

25 Nov, 2022 | 12:23h | UTC

Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan – JAMA Network Open

Commentaries:

Interstitial Lung Disease With Non–Vitamin K Oral Anticoagulants—A Clinical Concern? – JAMA Network Open

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs – TCTMD

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.